Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

Doctor Empathy After Your World Turns Upside Down!

Doctor Empathy After Your World Turns Upside Down!

This is how your world turns upside down in 10 seconds, when your doctor tells you, "I'm sorry"...

Award-winning journalist and author Mary Elizabeth Williams describes the moment her greatest fears were confirmed in this way.

On August 11, 2010, her doctor called and said, "We have reviewed your biopsy, and I am sorry to tell you this, but malignant melanoma is what you have."

In the book she has written since then, “A Series of Catastrophes and Miracles,” she recalls some very dark thoughts.

"This morning, while washing my hair, I studied my shampoo bottle and wondered whether I would be turned upside down... I wonder whether I will finish a box of oatmeal or whether a bottle of Tabasco will last longer. These are the things I think about these days, because I have stage 4 melanoma cancer..."

The book outlines what happened next, the medical procedures she underwent and the challenges of having to deal with cancer while the world goes on around you.

It ends on an optimistic note: ipilimumab (Yervoy) was the treatment in a clinical trial she joined, after which her cancer disappeared within a few weeks.

Williams was an invited guest at this year's ASCO Book Club event, held at the American Society of Clinical Oncology (ASCO) 2021 annual meeting.

She joined the medical oncologist at Memorial Sloan Kettering Cancer Center in New York City, Dr. Jedd D. Wolchok, who had invited her to the clinical trial and whom she considered "the man who ultimately saved my life", Jedd D. Wolchok.

Leading the discussion of the book was Ann H. Partridge, director of the Young and Strong Program for Young Women with Breast Cancer at Dana–Farber Cancer Institute in Boston, Massachusetts.

The book highlights "the importance of the patient-doctor relationship as its message," she said.

For Williams, it played a role in everything. "I really am always trying to impress upon people in the medical profession the importance of this respectful, collaborative relationship", she continued.

"If Jedd had been a different person, she probably would not have agreed to take part in the clinical trial. I began to feel that I trusted this person." she said.

Dr. Wolchok said it was about being "a good listener and partner" for patients. He first realized this in his third year of medical school, when one of his mentors said, "If you always treat your patients as a member of your family, you will never go wrong."

He said, "I try to approach it as an opportunity not to see the patient as a stranger and to think about what it is like to be on the 'other side' of the examination table". "What would I want if I were the one seeking treatment?"

Williams pointed out that she had not always experienced such empathy during her cancer journey. She described an excruciating moment that occurred while she was being evaluated for the clinical trial.

She was to be examined by a doctor who was part of the team. When he came to see her, he brought "a group of people" with him and said, "Oh, here is the tumor I was telling you about".

Although she could understand the distance doctors and nurses might maintain, and perhaps their need to protect themselves from emotional burnout, this was someone "who did not even look at me as a human being".

Even worse, she said, was the conversation that followed. The melanoma was both painful and very prominent on her back, and she had been told that a surgeon could remove it to make her more comfortable.

"Oh, no, no, no. If you want to be in this study, you cannot do that. We need that tumor," the doctor told her.

Williams said she was very surprised and demoralized.

"Here I was, someone facing death in a few months, leaving my children without a mother... and this person did not see me as a human being" she said.

Recent developments in melanoma

During the discussion, Partridge asked Dr. Wolchok to explain the progress made in recent years in melanoma treatment, particularly in immuno-oncology. Undoubtedly, the greatest advance in oncology since 2000 took place in melanoma with the drug ipilimumab, which received FDA approval in 2011, an immunotherapy. Previously, we had almost no promising treatment for advanced melanoma, but the enormous change now seen with immunotherapies, with survival extended from one year to 10 years in some patients, was described as “truly astonishing.”

Wolchok said that 10 years ago, doctors talked about participating in clinical trials because standard options "were not so acceptable," but now "we know how many people will benefit from immunotherapies that have now become standard treatments, and at least half of people benefit from this approach for initial treatment."

"We also know that clinical trials are still needed, because we are not yet treating 100% of people, and we will work until we do." he added.

When asked what he would say to young oncologists working in areas where immunotherapy has so far provided less benefit, such as pancreatic cancer, Wolchok replied, "Be stubborn."

This important change in the disease course for patients with melanoma occurred over the last 10 to 15 years. Before that, the prognosis (disease course) for patients with advanced melanoma was quite unfavorable; average survival was only 1 year.

Wolchok recalled being asked why he "would want to choose to specialize in a disease as depressing as melanoma".

He saw it as a challenge. There was so much we needed to do to improve patient outcomes.

Wolchok added, "For people still dealing with very challenging, complex diseases, I really believe we can get there. I do not know when, but it will be through the thoughtful integration of science into medicine."

Williams described scientific discovery as a "relay," with each breakthrough feeding into the next stage, and added that the same could be said of clinical care.

"If someone is not communicating well, is not compassionate, is not respectful, is not kind, is not inclusive, they have not tried hard enough." she explained.

And for the patient, their care does not end when their treatment ends.

Williams described how her husband Jeff became stressed, anxious and depressed, and she did not understand this until it was called "post-traumatic stress" for a reason.

The impact of cancer lasts "for the rest of your life", she continued.

There are ways to manage your side effects. You can manage your long-term chronic conditions. You can manage what you, your family, your employer and everyone around you have gone through and what that might look like in the long term.

"And I think there is such a rush in our culture, both outside medicine and certainly within health care: 'Okay, you are great. Goodbye.' "

For patients, therefore, finding support outside the cancer center is very important, she emphasized.

"There is so much conflicting information on the internet" she said, and "be careful with online support groups, because you will not find people who are doing well in those groups." She warned other patients against wandering around the internet if they wanted help.

Dr. Wolchok said that he and his colleagues were "very aware" of the pressures a melanoma diagnosis could place on a person, their family and friends.

"We encourage people to let go of feelings of taboo about seeing a mental health professional" he said. "Why not take advantage of the fact that there are actual mental health clinicians who know what it is like to survive for a long time with a disease most people do not survive for long, who know the 'anxiety'?" Psycho-oncology is a field in which you should consider consulting psychologists.

Williams also urged patients not to fall into the trap of being a "hero" or a "brave warrior."

"Be vulnerable. Being honest is the best thing you can be in this world."

Starting clinical trials

Partridge asked Williams what her message would be to encourage patients to participate in clinical trials.

She said that, first and foremost, her message would be to the people conducting clinical trials, to make them more inclusive and easier to access.

Williams also wants to see changes in some of the access parameters. She wants it to become easier to participate in clinical trials remotely and to see trials include people with comorbidities.

*

Sources

Davenport, L. (2021, June 25). Doctor Empathy After 'the Bottom Drops Out of Your World'. Medscape

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

Doctor Empathy After Your World Turns Upside Down!

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy